Table 2.
Characteristics of the people with multiple sclerosis (PwMS) in total and by year of diagnosis, and of the population-based matched references
PwMS | Matched references n = 7981 |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
2010 cohort | 2011 cohort | 2012 cohort | All PwMS | p valuea | |||||||
n = 611 | n = 706 | n = 671 | n = 1988 | ||||||||
n (%) | n (%) | n (%) | n (%) | n (%) | |||||||
Sociodemographic characteristicsb | |||||||||||
Sexc | 0.806 | ||||||||||
Women | 424 | 69.4 | 488 | 69.1 | 451 | 67.2 | 1363 | 68.6 | 5449 | 68.3 | |
Men | 187 | 30.6 | 218 | 30.9 | 220 | 32.8 | 625 | 31.4 | 2532 | 31.7 | |
Type of living areac | |||||||||||
Stockholm | 106 | 17.4 | 137 | 19.4 | 134 | 20.0 | 377 | 19.0 | 1509 | 18.9 | 0.993 |
Other large cities | 102 | 16.7 | 115 | 16.3 | 131 | 19.5 | 348 | 17.5 | 1382 | 17.3 | |
Medium-sized towns | 215 | 35.2 | 266 | 37.7 | 203 | 30.3 | 684 | 34.4 | 2741 | 34.3 | |
Small towns/rural areas | 188 | 30.8 | 188 | 26.6 | 203 | 30.3 | 579 | 29.1 | 2349 | 29.4 | |
Country of birthc | |||||||||||
Outside Sweden | 68 | 11.1 | 68 | 9.6 | 83 | 12.4 | 219 | 11.0 | 872 | 10.9 | 0.908 |
Sweden | 543 | 88.9 | 638 | 90.4 | 588 | 87.6 | 1769 | 89.0 | 7109 | 89.1 | |
Age (years)c | 0.906 | ||||||||||
19–24 | 99 | 16.2 | 105 | 14.9 | 126 | 18.8 | 330 | 16.6 | 1301 | 16.3 | |
25–34 | 188 | 30.8 | 213 | 30.2 | 192 | 28.6 | 593 | 29.8 | 2357 | 29.5 | |
35–44 | 188 | 30.8 | 223 | 31.6 | 206 | 30.7 | 617 | 31.0 | 2463 | 30.9 | |
45–55 | 136 | 22.3 | 165 | 23.4 | 147 | 21.9 | 448 | 22.5 | 1860 | 23.3 | |
Educational level | 0.497 | ||||||||||
No college/university | 392 | 64.2 | 437 | 61.9 | 440 | 65.6 | 1269 | 63.8 | 5029 | 63.0 | |
College or university | 219 | 35.8 | 269 | 38.1 | 231 | 34.4 | 719 | 36.2 | 2952 | 37.0 | |
Cohabiting/married | 0.190 | ||||||||||
No | 327 | 53.5 | 371 | 52.6 | 333 | 49.6 | 1031 | 51.9 | 4008 | 50.2 | |
Yes | 284 | 46.5 | 335 | 47.5 | 338 | 50.4 | 957 | 48.1 | 3973 | 49.8 | |
Children living at home | 0.002 | ||||||||||
No | 363 | 59.4 | 397 | 56.2 | 366 | 54.6 | 1126 | 56.6 | 4205 | 52.7 | |
Yes | 248 | 40.6 | 309 | 43.8 | 305 | 45.5 | 862 | 43.4 | 3776 | 47.3 | |
Type of work | 0.026 | ||||||||||
Manager | 14 | 2.3 | 25 | 3.5 | 12 | 1.8 | 51 | 2.6 | 304 | 3.8 | |
Office work | 190 | 31.1 | 243 | 34.4 | 236 | 35.2 | 669 | 33.7 | 2805 | 35.2 | |
Manual labour and customer service | 276 | 45.2 | 298 | 42.2 | 292 | 43.5 | 866 | 43.6 | 3373 | 42.3 | |
Unspecified work | 57 | 9.3 | 54 | 7.7 | 61 | 9.1 | 172 | 8.7 | 606 | 7.6 | |
Not in paid work | 74 | 12.1 | 86 | 12.2 | 70 | 10.4 | 230 | 11.6 | 893 | 11.2 | |
Comorbidity in Y−4d | |||||||||||
Depression/anxietye | 0.048 | ||||||||||
No | 543 | 88.9 | 619 | 87.7 | 589 | 87.8 | 1751 | 88.1 | 7152 | 89.6 | |
Yes | 68 | 11.1 | 87 | 12.3 | 82 | 12.2 | 237 | 11.9 | 829 | 10.4 | |
Painf | <.0001 | ||||||||||
No | 491 | 80.4 | 556 | 78.8 | 516 | 76.9 | 1563 | 78.6 | 6599 | 82.7 | |
Yes | 120 | 19.6 | 150 | 21.3 | 155 | 23.1 | 425 | 21.4 | 1382 | 17.3 | |
Comorbidity categoriesg | 0.002 | ||||||||||
0 | 169 | 27.7 | 196 | 27.8 | 196 | 29.2 | 561 | 28.2 | 2533 | 31.7 | |
1–2 | 333 | 54.5 | 371 | 52.6 | 350 | 52.2 | 1054 | 53.0 | 4082 | 51.2 | |
3–4 | 73 | 12.0 | 89 | 12.6 | 92 | 13.7 | 254 | 12.8 | 1010 | 12.7 | |
5+ | 36 | 5.9 | 50 | 7.1 | 33 | 4.9 | 119 | 6.0 | 356 | 4.5 |
ATC Anatomical Therapeutic Chemical Classification System, DMT disease-modifying therapy, MS multiple sclerosis, SPDR Swedish Prescribed Drug Register
aP-value calculated with Pearson’s Chi2 tests. Differences in proportions were tested between all PwMS and the matched references without MS, p < 0.05
bSociodemographic characteristics measured at baseline (match date 31 December Y-5). Individuals with missing values were placed in the lowest category
cVariables used in matching 1:4, with age matched in exact years. Subsequent exclusions because of death or emigration, and for sickness absence or disability pension due to MS among the matched references, mean that the numbers presented no longer sum exactly to a 1:4 ratio
dComorbidity and drug information with regard to the entire calendar year of the first (Y−4) study year
eAnxiety/depression was identified from the respective RxRisk Comorbidity index categories according to the SPDR by ATC codes: N05BA01-N05BA56; N05BE01; N06AA01-N06AG02; N06AX01-N06AX11; N06AX13-N06AX26; and N06AX12
fPain drugs were identified from the respective RxRisk Comorbidity index categories according to the SPDR by ATC codes: M01AB01-M01AX01; and N02AA01-N02AX99
gComorbidity is according to a modified RxRisk Comorbidity index constructed by ATC codes from the SPDR or whether in the Swedish Cancer Register, excluding MS DMTs (ATC codes: L03AB07; L03AB08; L03AB13; L03AX13; L04AA31; L04AA23; L04AA27; L04AA34; L01XC02; L04AC01; and N07XX09). Comorbidity refers to the number of condition categories within the calendar year